Fill out this form to email this article to a friend
FDA approves drug for chronic hepatitis B
By ASSOCIATED PRESS
Published October 26, 2006
WASHINGTON - The tens of thousands of people in the United States who are infected by hepatitis B each year gained a new drug on Wednesday to fight the virus. The Food and Drug Administration said it approved Tyzeka, known generically as telbivudine, for use by adults with chronic hepatitis B. The drug is not a cure, but can suppress the virus and reduce the liver inflammation that accompanies it, the FDA said. Hepatitis B can cause scarring, cancer and failure of the liver, as well as death. There are now six FDA-approved drugs to treat hepatitis B.
[Last modified October 26, 2006, 02:37:04]
Share your thoughts on this story
|
News
Fifty years ago, they were screwed-up kids sent to the Florida School for Boys to be straightened out. But now they are screwed-up men, scarred by the whippings they endured. Read the story and see a video and portrait gallery.
Print
Email story
Comment
Email editor
